All Drugs
NSAID · Non-selective COX Inhibitor — Non-steroidal Anti-inflammatory Drug (NSAID)

Indomethacin (indomethacin)

Also sold as: Indocid, Indoflam, Intagesic, Indocin

Pregnancy

Cat C

Lactation

Caution

Schedule

H

Forms

Capsules 25 mg +4

Indications

Adult Dosing

Acute gout attack

50 mg orally three times daily

For 3–5 days until acute attack resolves; then taper to 25 mg TDS for 2–3 days

One of the most potent NSAIDs for acute gout. Take with food to minimise GI side effects. Avoid in elderly, peptic ulcer disease, renal impairment, or cardiovascular disease. Naproxen or celecoxib preferred in patients at higher GI/CV risk.

Ankylosing spondylitis

25–50 mg orally three times daily; or sustained-release 75 mg once to twice daily

Long-term; use minimum effective dose

Indomethacin is particularly effective in ankylosing spondylitis (AS) — one of the few NSAIDs with evidence for slowing radiographic progression in AS. Monitor renal function, blood pressure, and GI status on long-term therapy. Add a PPI for GI protection.

Osteoarthritis and rheumatoid arthritis

25–50 mg orally two to three times daily

Shortest duration at lowest effective dose; reassess regularly

Reserved for cases not responding to less potent NSAIDs (ibuprofen, naproxen) due to higher toxicity profile.

Maximum daily dose: 200 mg/day (150–200 mg in divided doses for inflammatory conditions)

Pediatric Dosing

Age Range: Neonates (IV PDA closure only)
Dose: 0.1–0.3 mg/kg IV × 3 doses at 12–24h intervals; dose 1: 0.1–0.2 mg/kg; doses 2–3: age-dependent 0.1–0.25 mg/kg

Hold if urine output <0.6 mL/kg/hr. Monitor renal function. Not for standard paediatric use.

Calculate exact mL by weight →

Renal Dose Adjustment

CrCl / eGFRDose Adjustment
CrCl <30 mL/minAvoid — NSAIDs reduce renal prostaglandin synthesis and can cause acute renal injury, sodium and water retention, and hyperkalaemia
CrCl ≥30 mL/minShort-course use only (3–5 days) in mild CKD with close renal monitoring; avoid long-term use in any CKD
Calculate eGFR / CrCl →

Hepatic Adjustment

Use with caution in hepatic impairment — indomethacin is extensively hepatically metabolised. Avoid in severe hepatic disease. Risk of hepatotoxicity and fluid retention in decompensated cirrhosis.

Pregnancy & Lactation

Pregnancy: Category C

Category C in first and second trimesters — avoid if possible; use only when benefit clearly outweighs risk. Category D/X in the third trimester — premature closure of the ductus arteriosus; also associated with oligohydramnios (reduces fetal renal perfusion), fetal renal toxicity, and delayed parturition. Contraindicated after 30 weeks gestation. Before 30 weeks: short-term use only with fetal monitoring.

Lactation: Caution

Indomethacin is excreted in breast milk. Isolated reports of neonatal seizures in breastfed infants (neonates have reduced ability to metabolise indomethacin). Ibuprofen is preferred for nursing mothers as it has lower milk transfer and better safety data.

Top Drug Interactions

Interacting DrugEffectSeverity
Warfarin and anticoagulantsIndomethacin inhibits platelet aggregation and may cause GI bleeding; combined with anticoagulants, this significantly increases haemorrhagic risk. Also displaces warfarin from protein binding — raises INR. Monitor INR closely; avoid combination if possibleMajor
LithiumNSAIDs reduce renal prostaglandin synthesis, decrease lithium excretion, and increase serum lithium levels by 25–60% — lithium toxicity risk (tremor, confusion, arrhythmia). Monitor lithium levels closely or use sulindac (least interaction among NSAIDs)Major
Aspirin (concurrent anti-platelet dose)Indomethacin competes with aspirin for COX-1 binding, reducing the antiplatelet effect of aspirin. Combined use also significantly increases GI bleeding riskMajor
ACE inhibitors and ARBsNSAIDs blunt the antihypertensive effect (prostaglandin-mediated renal mechanism) and combined with ACEi/ARB increase nephrotoxicity risk — avoid in CKD; monitor blood pressure and renal functionModerate
SSRIs (fluoxetine, sertraline, escitalopram)Additive risk of GI bleeding — SSRIs deplete platelet serotonin (impair platelet aggregation) and combined with NSAID GI toxicity significantly increases upper GI haemorrhage risk; add PPI if combination unavoidableModerate

DoctorScribe — AI Medical Scribe

Stop looking up Indomethacin — just speak the prescription

"Indomethacin as per dose, BD for 5 days." DoctorScribe writes the full prescription with brand, strength, frequency, and route — auto-applies pediatric weight-based dosing and renal adjustments. Try the live demo.

Side Effects

Common

  • Gastrointestinal upset, nausea, dyspepsia (most common — take with food)
  • Headache (including frontal headache — indomethacin-specific; may be dose-limiting)
  • Dizziness and lightheadedness
  • Fluid retention and ankle oedema
  • Elevated blood pressure
  • Peptic ulceration (with long-term or high-dose use)

Serious / Discontinue If

  • Gastrointestinal bleeding and peptic ulceration — high GI toxicity (one of the highest among NSAIDs); use PPI concomitantly
  • Acute kidney injury — especially in volume-depleted patients, elderly, and CKD
  • Cardiovascular events (MI, stroke) — all NSAIDs carry CV risk; higher with indomethacin at high doses or prolonged use
  • Hypersensitivity reactions — bronchospasm, anaphylaxis (especially in aspirin-sensitive asthma patients)
  • CNS effects — headache, dizziness, confusion, psychiatric disturbances (indomethacin crosses blood-brain barrier more than other NSAIDs)
  • Hepatotoxicity (rare)
  • Neonatal PDA use: renal impairment, oliguria, necrotising enterocolitis, intracranial haemorrhage (monitor closely)

Contraindications

Available Indian Brands

BrandManufacturerPrice (approx)
Indocid 25 mg CapsulesMSD India₹28/10 capsules
Indoflam 25 mg CapsulesCipla₹22/10 capsules
Intagesic 25 mg CapsulesElder Pharmaceuticals₹18/10 capsules

Monitoring Required

Patient Counseling Points

Stop Googling drug references mid-consultation

EasyClinic auto-flags Indomethacin interactions, renal cutoffs, and pregnancy warnings the moment you write the prescription. Built-in safety net for every Indian doctor.

Start 7-Day Free Trial

Clinically reviewed by: Dr. Pradeep Sharma, MD (Medicine), DM (Rheumatology), Consultant Rheumatologist

Last reviewed: 2026-04-15

References

  • Schumacher HR Jr, et al. Randomised double-blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ. 2002;324(7352):1488–1492.
  • Zochling J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006;65(4):442–452.
  • Van Overmeire B, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 2000;343(10):674–681.
  • MSD India. Indocid prescribing information. 2024.
Disclaimer: This information is for clinical reference only. It is not exhaustive and does not substitute clinical judgement. Always verify current dosing against the manufacturer's prescribing information and current treatment guidelines. Drug prices are approximate and may vary.